Results 171 to 180 of about 7,072 (218)

Albumin, urea-to-albumin ratio, or the albumin-to-creatinine ratio to predict outcomes in heart failure with mildly reduced ejection fraction. [PDF]

Eur J Clin Invest
Schmitt A, Akin I, Reinhardt M, Abel N, Lau F, Dudda J, Abumayyaleh M, Weidner K, Bertsch T, Duerschmied D, Behnes M, Schupp T.   +11 more
europepmc   +1 more source

Finerenone in diabetic chronic kidney disease-Real-world insights including patients with HFpEF or HFmrEF. [PDF]

ESC Heart Fail
Hellenkamp K, Kaebe S, Valentova M, von Haehling S, Delistefani F, Gollisch K, Raddatz D, Schäfer AK, Koziolek MJ, Wallbach M.   +9 more
europepmc   +1 more source

Agreement of thermodilution and direct Fick methods for cardiac output across varying haemodynamic conditions. [PDF]

ESC Heart Fail
Melin M, Löfman IH, Matan D, Nygren M, Shahim B, Lund LH, Manouras A.   +6 more
europepmc   +1 more source

Distinct mortality patterns and sudden cardiac death mechanisms in heart failure with a preserved ejection fraction. [PDF]

Sci Rep
Sobue Y, Watanabe E, Yanase M, Izawa H.
europepmc   +1 more source

The hemoglobin glycation index stratifies heart failure phenotypes and in-hospital risk. [PDF]

Front Endocrinol (Lausanne)
Lyu C, Tong X, Fu P, Gao Y, Hua J, Zhao J, Yu P, Chen X, Lyu D.   +8 more
europepmc   +1 more source

Valvular Heart Disease and Its Association With Death in Advanced Heart Failure. [PDF]

J Am Heart Assoc
Steiger KG, Harmon DM, Killian JM, Nkomo VT, Redfield M, Dunlay SM.   +5 more
europepmc   +1 more source

Very long-term LVEF dynamics and prognosis in HFrEF and HFmrEF

, 2017
de Antonio, M, Lupon, J, Lopez-Ayerbe, J, Moliner, P, Domingo, M, Ferrer, E, Zamora, E, Vallejo, N, Gual, F, Teis, A, Junca, G, Troya, MI, Rodriguez, M, Gonzalez, B, Bayes-Genis, A   +14 more
openaire   +1 more source

Biomarker, Functional Status, and Quality-of-Life Trajectories Before Modes of Death in Heart Failure: Post Hoc Analysis of the FINEARTS-HF Randomized Clinical Trial.

JAMA Cardiol
Lu H, Kosztin A, Claggett BL, Foà A, Pabón MA, Desai AS, Jhund PS, Henderson AD, Merkely B, Lam CSP, Senni M, Shah SJ, Voors AA, Zannad F, Pitt B, Amarante F, Saarinen R, De Sanctis Y, Glasauer A, McMurray JJV, Vaduganathan M, Solomon SD.   +21 more
europepmc   +1 more source

CMR Tissue Characterization in Patients with HFmrEF [PDF]

Journal of Clinical Medicine, 2019
The characteristics and optimal management of heart failure with a moderately reduced ejection fraction (HFmrEF, LV-EF 40–50%) are still unclear. Advanced cardiac MRI offers information about function, fibrosis and inflammation of the myocardium, and might help to characterize HFmrEF in terms of adverse cardiac remodeling.
Patrick Doeblin, Djawid Hashemi, Radu Tanacli   +2 more
exaly   +3 more sources